PROKIDNEY CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.2 USD | +2.33% |
|
+3.77% | +23.60% |
| 25/03 | ProKidney Corp. Announces Key Leadership Appointments Strengthening Clinical and Technical Operations | CI |
| 22/03 | ProKidney Posts Wider 2023 Loss | MT |
Chart calendar ProKidney Corp.
cf1abfa3ec99a354b0e56e3903.GZmqAb6KPRPiCxlw8Py8RhF8Gtu2fjBj5BsWoALFtCs.WvPcVeHPbX2sYnAGt53RACgNbJz-Bmkm1ktD7TCm4h1x-J9C4dJleqdaUA~36a1d7b9a2cdf70e381c5a228ef12f8d
Upcoming events on ProKidney Corp.
Past events on ProKidney Corp.
| 22/03/2024 05:19 am | Q4 2023 Earnings Release |
| 12/03/2024 | Jefferies Biotech on the Bay Summit |
| 30/11/2023 06:25 pm | Evercore ISI HealthCONx Conference |
| 14/11/2023 06:30 pm | REACT RMCL-002 Phase 2 Clinical Trial Results Call |
| 14/11/2023 04:35 pm | Q3 2023 Earnings Release |
| 04/11/2023 07:30 pm | American Society of Nephrology Kidney Conference - Poster Number #: SA-PO354 |
| 03/11/2023 07:30 pm | American Society of Nephrology Kidney Conference - Poster Number #: FR-PO637 |
| 02/11/2023 07:30 pm | American Society of Nephrology Kidney Conference - Poster Number #: TH-PO739 |
| 02/11/2023 07:30 pm | American Society of Nephrology Kidney Conference - Poster Number #: TH-PO169 |
| 11/09/2023 09:45 pm | Morgan Stanley Global Healthcare Conference |
| 11/08/2023 01:40 am | Q2 2023 Earnings Release |
| 29/06/2023 07:30 pm | Annual General Meeting |
| 09/06/2023 01:30 am | Jefferies Global Healthcare Conference |
| 12/05/2023 01:31 am | Q1 2023 Earnings Release |
| 10/05/2023 04:50 am | Bank of America Healthcare Conference |
| 29/03/2023 01:42 am | Q4 2022 Earnings Release |
| 07/03/2023 09:00 pm | Cowen Health Care Conference |
| 12/01/2023 05:15 am | JP Morgan Healthcare Conference |
| 01/12/2022 08:35 pm | Evercore ISI HealthCONx Conference |
| 16/11/2022 05:50 pm | Jefferies London Healthcare Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -150 -139 -7.97% | -148 -147 -0.58% | -192 |
|
EBIT Million USD | Released Forecast Spread | -153 -148 -3.62% | -152 -155 2.36% | -187 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -147 -164 10% | -159 -153 -3.9% | -175 |
|
Net income Million USD | Released Forecast Spread | -108 -142 23.91% | -35,5 -100 64.7% | -157 |
|
EPS USD | Released Forecast Spread | -0,23 -2,34 90.17% | -0,57 -0,65 11.63% | -1,28 |
| Announcement Date | 28/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -34,8 -47,0 25.98% | -29,4 | -23,1 -42,6 45.87% | -40,7 | ||||||
|
EBIT Million USD | Released Forecast Spread | -35,6 -47,0 24.31% | -30,2 -41,2 26.64% | -40,9 -44,0 7.1% | -39,8 -41,7 4.4% | -46,6 -41,8 -11.5% | -24,2 -44,6 45.73% | -39,9 | -43,1 | -47,2 | -50,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,8 -42,2 38.78% | -33,9 -35,8 5.49% | -41,1 -35,8 -14.61% | -18,9 -42,9 55.91% | -36,7 | -33,6 | -34,7 | -35,9 | ||
|
Net income Million USD | Released Forecast Spread | -11,9 -47,0 74.62% | -6,49 -27,5 76.42% | -9,67 -44,0 78.03% | -9,12 -31,2 70.76% | -11,0 -9,32 -17.85% | -5,70 -31,9 82.14% | -36,2 | -40,3 | -44,4 | -36,4 |
|
EPS USD | Released Forecast Spread | -0,13 -0,76 82.89% | -0,11 -0,45 75.28% | -0,14 -0,47 70.21% | -0,18 -0,15 -20% | -0,09 -0,18 50% | -0,35 | -0,54 | -0,55 | -0,57 | |
| Announcement Date | 14/11/22 | 28/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 22/03/24 | - | - | - | - |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for ProKidney Corp.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PROK Stock
- Calendar ProKidney Corp.
